ELVN
Price
$25.80
Change
-$0.00 (-0.00%)
Updated
Nov 13 closing price
118 days until earnings call
LABFF
Price
$90.61
Change
-$0.00 (-0.00%)
Updated
Jul 1 closing price
Ad is loading...

ELVN vs LABFF

Header iconELVN vs LABFF Comparison
Open Charts ELVN vs LABFFBanner chart's image
Enliven Therapeutics
Price$25.80
Change-$0.00 (-0.00%)
Volume$279.93K
CapitalizationN/A
LABORATORIOS FARMACEUTICOS ROVI SA
Price$90.61
Change-$0.00 (-0.00%)
Volume$100
CapitalizationN/A
ELVN vs LABFF Comparison Chart
Loading...
ELVN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
ELVN vs. LABFF commentary
Nov 15, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ELVN is a Hold and LABFF is a Hold.

COMPARISON
Comparison
Nov 15, 2024
Stock price -- (ELVN: $25.80 vs. LABFF: $90.61)
Brand notoriety: ELVN and LABFF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ELVN: 100% vs. LABFF: 100%
Market capitalization -- ELVN: $1.18B vs. LABFF: $3.54B
ELVN [@Biotechnology] is valued at $1.18B. LABFF’s [@Biotechnology] market capitalization is $3.54B. The market cap for tickers in the [@Biotechnology] industry ranges from $475.76B to $0. The average market capitalization across the [@Biotechnology] industry is $2.77B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ELVN’s FA Score shows that 0 FA rating(s) are green whileLABFF’s FA Score has 2 green FA rating(s).

  • ELVN’s FA Score: 0 green, 5 red.
  • LABFF’s FA Score: 2 green, 3 red.
According to our system of comparison, LABFF is a better buy in the long-term than ELVN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ELVN’s TA Score shows that 4 TA indicator(s) are bullish.

  • ELVN’s TA Score: 4 bullish, 5 bearish.

Price Growth

ELVN (@Biotechnology) experienced а -12.69% price change this week, while LABFF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.83%. For the same industry, the average monthly price growth was +3.51%, and the average quarterly price growth was +5.54%.

Reported Earning Dates

ELVN is expected to report earnings on Mar 13, 2025.

Industries' Descriptions

@Biotechnology (-1.83% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LABFF($3.54B) has a higher market cap than ELVN($1.18B). ELVN YTD gains are higher at: 86.416 vs. LABFF (74.250).
ELVNLABFFELVN / LABFF
Capitalization1.18B3.54B33%
EBITDAN/AN/A-
Gain YTD86.41674.250116%
P/E RatioN/A28.85-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
TECHNICAL ANALYSIS
Technical Analysis
ELVN
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
85%
Momentum
ODDS (%)
Bearish Trend 2 days ago
87%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 9 days ago
0%
Declines
ODDS (%)
Bearish Trend 2 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
78%
View a ticker or compare two or three
Ad is loading...
ELVN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X90584.1640002628.351600
+2.99%
Bitcoin cryptocurrency
TSLA330.241.75
+0.53%
Tesla
AAPL225.120.89
+0.40%
Apple
SPY597.190.29
+0.05%
SPDR® S&P 500® ETF Trust
GME26.46-0.38
-1.42%
GameStop Corp

ELVN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ELVN has been loosely correlated with CRNX. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if ELVN jumps, then CRNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ELVN
1D Price
Change %
ELVN100%
-5.04%
CRNX - ELVN
43%
Loosely correlated
+0.24%
VYGR - ELVN
41%
Loosely correlated
-2.05%
LABFF - ELVN
39%
Loosely correlated
N/A
ACLX - ELVN
38%
Loosely correlated
-0.34%
SER - ELVN
37%
Loosely correlated
-3.66%
More

LABFF and

Correlation & Price change

A.I.dvisor indicates that over the last year, LABFF has been closely correlated with XTLB. These tickers have moved in lockstep 70% of the time. This A.I.-generated data suggests there is a high statistical probability that if LABFF jumps, then XTLB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LABFF
1D Price
Change %
LABFF100%
N/A
XTLB - LABFF
70%
Closely correlated
N/A
ELVN - LABFF
39%
Loosely correlated
-5.04%
CRNX - LABFF
35%
Loosely correlated
+0.24%
TOVX - LABFF
27%
Poorly correlated
-0.70%
BCLI - LABFF
26%
Poorly correlated
-0.85%
More